162 related articles for article (PubMed ID: 28121292)
1. Ranpirnase eradicates human papillomavirus in cultured cells and heals anogenital warts in a Phase I study.
Squiquera L; Taxman DJ; Brendle SA; Torres R; Sulley J; Hodge T; Christensen N; Sidransky D
Antivir Ther; 2017; 22(3):247-255. PubMed ID: 28121292
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia.
Sanclemente G; Herrera S; Tyring SK; Rady PL; Zuleta JJ; Correa LA; He Q; Wolff JC
J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1054-60. PubMed ID: 17714124
[TBL] [Abstract][Full Text] [Related]
3. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study.
Saiag P; Bauhofer A; Bouscarat F; Aquilina C; Ortonne JP; Dupin N; Mougin C
Br J Dermatol; 2009 Oct; 161(4):904-9. PubMed ID: 19466962
[TBL] [Abstract][Full Text] [Related]
4. Topical Polyphenon E in the treatment of external genital and perianal warts: a randomized controlled trial.
Stockfleth E; Beti H; Orasan R; Grigorian F; Mescheder A; Tawfik H; Thielert C
Br J Dermatol; 2008 Jun; 158(6):1329-38. PubMed ID: 18363746
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial).
Murray ML; Meadows J; Doré CJ; Copas AJ; Haddow LJ; Lacey C; Jit M; Soldan K; Bennett K; Tetlow M; Nathan M; Gilson R
BMC Med Res Methodol; 2018 Nov; 18(1):125. PubMed ID: 30400777
[TBL] [Abstract][Full Text] [Related]
6. [Topical imiquimod cream in the treatment of external anogenital warts: personal experience].
Senatori R; Dionisi B; Lippa P; Inghirami P
Minerva Ginecol; 2003 Dec; 55(6):541-6. PubMed ID: 14676745
[TBL] [Abstract][Full Text] [Related]
7. Treatment of intraurethral condylomata acuminata with surgery and cidofovir instillations in two immunocompromised patients and review of the literature.
Florin HJ; Snoeck R; Van Cleynenbreugel B; Albersen M
Antiviral Res; 2018 Oct; 158():238-243. PubMed ID: 30153444
[TBL] [Abstract][Full Text] [Related]
8. Distribution of human papillomavirus types in anogenital warts of men.
Chan PK; Luk AC; Luk TN; Lee KF; Cheung JL; Ho KM; Lo KK
J Clin Virol; 2009 Feb; 44(2):111-4. PubMed ID: 19097933
[TBL] [Abstract][Full Text] [Related]
9. Genital warts.
Steben M; Garland SM
Best Pract Res Clin Obstet Gynaecol; 2014 Oct; 28(7):1063-73. PubMed ID: 25155525
[TBL] [Abstract][Full Text] [Related]
10. Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.
Park IU; Introcaso C; Dunne EF
Clin Infect Dis; 2015 Dec; 61 Suppl 8():S849-55. PubMed ID: 26602622
[TBL] [Abstract][Full Text] [Related]
11. Tumor-specific and gender-specific pre-vaccination distribution of human papillomavirus types 6 and 11 in anogenital warts and laryngeal papillomas: a study on 574 tissue specimens.
Komloš KF; Kocjan BJ; Košorok P; Luzar B; Meglič L; Potočnik M; Hočevar-Boltežar I; Gale N; Seme K; Poljak M
J Med Virol; 2012 Aug; 84(8):1233-41. PubMed ID: 22711351
[TBL] [Abstract][Full Text] [Related]
12. [Papillomavirus-induced anogenital lesions in 121 HIV seropositive men. Clinical, histological, viral study, and evolution].
Voltz JM; Drobacheff C; Derancourt C; Coumes-Marquet S; Mougin C; Laurent R
Ann Dermatol Venereol; 1999 May; 126(5):424-9. PubMed ID: 10434106
[TBL] [Abstract][Full Text] [Related]
13. The cytotoxic mechanism of epigallocatechin gallate on proliferative HaCaT keratinocytes.
Chu YW; Liu ST; Yang YL; Huang SM; Wang WM
J Biomed Sci; 2017 Aug; 24(1):55. PubMed ID: 28810862
[TBL] [Abstract][Full Text] [Related]
14. Randomised controlled trial of 1% and 5% 5-fluorouracil creams compared with 90% trichloroacetic acid solution for anogenital wart treatment.
Anggraini I; Hoemardani AS; Nilasari H; Indriatmi W
Int J STD AIDS; 2020 Aug; 31(9):849-858. PubMed ID: 32605501
[TBL] [Abstract][Full Text] [Related]
15. Anogenital human papilloma virus and the problem of persistence.
Syrjänen K
Eur J Dermatol; 1998; 8(7 Suppl):5-7; discussion 20-2. PubMed ID: 10387956
[TBL] [Abstract][Full Text] [Related]
16. A new mode of treatment of human papilloma virus associated anogenital lesions using a nonsteroid estrogen analogue.
Schön HJ; Grgurin M; Szekeres T; Schurz B
Wien Klin Wochenschr; 1996; 108(2):45-7. PubMed ID: 8835432
[TBL] [Abstract][Full Text] [Related]
17. Topical treatment for human papillomavirus-associated genital warts in humans with the novel tellurium immunomodulator AS101: assessment of its safety and efficacy.
Friedman M; Bayer I; Letko I; Duvdevani R; Zavaro-Levy O; Ron B; Albeck M; Sredni B
Br J Dermatol; 2009 Feb; 160(2):403-8. PubMed ID: 18808418
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of human papillomaviruses infection in men with genital warts in Shanghai.
Chen X; Li L; Lai Y; Liu Q; Yan J; Tang Y
Oncotarget; 2016 Aug; 7(33):53903-53910. PubMed ID: 27270315
[TBL] [Abstract][Full Text] [Related]
19. [Genital warts in HIV-infected individuals].
Wieland U; Kreuter A
Hautarzt; 2017 Mar; 68(3):192-198. PubMed ID: 28160045
[TBL] [Abstract][Full Text] [Related]
20. Antiviral effect of ranpirnase against Ebola virus.
Hodge T; Draper K; Brasel T; Freiberg A; Squiquera L; Sidransky D; Sulley J; Taxman DJ
Antiviral Res; 2016 Aug; 132():210-8. PubMed ID: 27350309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
